Neurocognitive Disorders Clinical Trial
Official title:
The Effect of Intraoperative Arterial Oxygen Levels on Cognitive Functions After Coronary Bypass Graft Surgery
Verified date | March 2023 |
Source | Bursa Yüksek Ihtisas Education and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to examine the effects of different but safe levels of arterial oxygen levels used in cardiac surgeries on cerebral oxygenation during the operation. It is also to investigate the effect on cognitive functions in the postoperative period. For our study the investigators will conduct a randomized control trial. Patients will be randomly assigned to one of two possible study groups according to the arterial oxygen levels.If there is any abnormality in cerebral oxygen levels during surgery, necessary intervention will be made by doctors.
Status | Completed |
Enrollment | 100 |
Est. completion date | August 1, 2020 |
Est. primary completion date | May 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - adult patients scheduled to undergo elective cardiopulmonary bypass graft surgery Exclusion Criteria: - severe preoperative cognitive impairment(i.e. dementia, intellectual disorder) - Non-Turkish speaking patients - presence of end-stage organ failure - patients requiring emergency coronary surgery - surgical procedures requiring single lung ventilation |
Country | Name | City | State |
---|---|---|---|
Turkey | Bursa YIERH | Bursa |
Lead Sponsor | Collaborator |
---|---|
Bursa Yüksek Ihtisas Education and Research Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | postoperative neurocognitive function | Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language. | 12 hours after surgery | |
Primary | postoperative neurocognitive function | Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language. | 24 hours after surgery | |
Primary | postoperative neurocognitive function | Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language. | 1 month after surgery | |
Primary | postoperative neurocognitive function | Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language. | 3 months after surgery | |
Primary | postoperative neurocognitive function | Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language. | 6 months after surgery | |
Secondary | Extubation time after surgery | Weaning times from mechanical ventilation among patients who are followed up with the same intensive care approach after surgery | During the hospitalization for postoperative recovery ,average 8 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05754567 -
CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
|
||
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Not yet recruiting |
NCT03276377 -
VItamin K Inhibition and NeurocoGnition (VIKING)
|
N/A | |
Completed |
NCT04175223 -
Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders
|
N/A | |
Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
Recruiting |
NCT05732285 -
A Pilot Randomized Controlled Trial: CoINTEGRATE
|
N/A | |
Recruiting |
NCT04095962 -
Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia
|
N/A | |
Not yet recruiting |
NCT04113577 -
COgilus Remediation in Alzheimer Patients (CORA)
|
||
Recruiting |
NCT06320639 -
DRIVing Simulator and People With NeuroCognitive Disorders
|
||
Recruiting |
NCT06105320 -
COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study
|
N/A | |
Completed |
NCT03050385 -
Cognitive Rehabilitation During Transcranial Direct Current Stimulation
|
N/A | |
Active, not recruiting |
NCT06372002 -
Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia
|
N/A | |
Recruiting |
NCT05508789 -
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
|
Phase 3 | |
Recruiting |
NCT03926351 -
High Dose Omega 3 in People at Risk for Dementia
|
Phase 2 | |
Recruiting |
NCT05504681 -
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
|
||
Completed |
NCT04168268 -
Patient-reported Outcome Measures After Post-anesthesia Care Unit Delirium
|
||
Recruiting |
NCT04825847 -
Neurocognitive Disorders After Major Surgery in Elderly
|
N/A | |
Active, not recruiting |
NCT02958670 -
Imaging Tau Deposition in the Brain of Elderly Subjects
|
N/A | |
Enrolling by invitation |
NCT02652598 -
Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD
|
Phase 2 | |
Completed |
NCT02825732 -
MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint
|
N/A |